The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Bpc 157 bone healing: 2025's Crucial Warning. FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest